Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets.

It further said that the single-dose ampules are both bioequivalent and therapeutically equivalent to the reference listed ...

The uptick in Glenmark Pharmaceuticals share price came after the company announced the launch of Phytonadione Injectable ...

Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules: Our Bureau, Mumbai Tuesday, January 21, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

Glenmark Pharmaceuticals on Tuesday, January 21, said its US arm has launched Phytonadione Injectable Emulsion USP, 10mg/ml ...

According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market 2 achieved annual sales of approximately $19.7 million*.

(RTTNews) - Glenmark Pharmaceuticals Inc., USA (GLENMARK.NS), Thursday announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

The Nifty breached the 23,000 mark intra-day for the first time since June 2024, closing at 23,025, down 320 points. The Sensex also shed 1,235 points to settle at 75,838.

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.